Copyright
©The Author(s) 2016.
World J Hepatol. Jun 8, 2016; 8(16): 685-690
Published online Jun 8, 2016. doi: 10.4254/wjh.v8.i16.685
Published online Jun 8, 2016. doi: 10.4254/wjh.v8.i16.685
P-values | Kappa values | ||
Reader #1 | Reader #2 | ||
Arterial-phase nodular enhancement | 0.44 | 0.14 | 0.37 (fair agreement) |
Arterial-phase non-nodular enhancement | 0.25 | 0.008b | 0.23 (fair agreement) |
Gradual enhancement | 0.47 | 0.15 | 0.10 (slight agreement) |
Partial or complete T1 signal hypointensity | 0.21 | 0.001b | 0.15 (slight agreement) |
Partial or complete T2 signal hyperintensity | 0.047a | 0.47 | 0.07 (slight agreement) |
Lipid | 0.56 | 0.44 | -0.03 (no agreement) |
Restricted diffusion | N/A1 | N/A1 | N/A1 |
- Citation: Becker-Weidman D, Civan JM, Deshmukh SP, Roth CG, Herrine SK, Parker L, Mitchell DG. Hepatocellular carcinoma after locoregional therapy: Magnetic resonance imaging findings in falsely negative exams. World J Hepatol 2016; 8(16): 685-690
- URL: https://www.wjgnet.com/1948-5182/full/v8/i16/685.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i16.685